background
emerg
reemerg
infecti
diseas
novel
coronaviru
diseas
ebola
pose
signific
threat
global
societi
test
public
health
commun
prepared
rapidli
respond
outbreak
effect
diagnost
therapeut
recent
advanc
next
gener
sequenc
technolog
enabl
rapid
gener
pathogen
genom
sequenc
data
within
hour
obtain
sampl
instanc
data
one
quickli
evalu
effect
exist
diagnost
therapeut
use
silico
approach
propens
virus
rapidli
accumul
mutat
lead
failur
molecular
detect
assay
creat
need
redesign
newli
design
assay
result
describ
bioinformat
system
name
biolaboro
identifi
signatur
region
given
pathogen
genom
design
pcr
assay
target
region
test
pcr
assay
silico
determin
sensit
specif
demonstr
biolaboro
two
use
case
bombali
ebolaviru
bomv
novel
coronaviru
bomv
analyz
current
avail
realtim
revers
transcriptionpcr
assay
three
avail
complet
genom
sequenc
bomv
two
met
silico
criteria
success
detect
neither
perfect
match
primerprob
sequenc
design
five
new
primer
set
bomv
signatur
true
posit
hit
three
bomv
genom
fals
posit
hit
sequenc
four
assay
close
cluster
nucleoprotein
gene
one
locat
glycoprotein
gene
similarli
design
five
highli
specif
primer
set
hit
whole
genom
avail
februari
none
near
neighbor
biorxiv
preprint
conclus
appli
biolaboro
two
realworld
use
case
demonstr
capabl
identifi
signatur
region
assess
efficaci
exist
pcr
assay
detect
pathogen
evolv
time
design
new
assay
perfect
silico
detect
accuraci
within
hour
develop
deploy
biolaboro
design
userfriendli
graphic
user
interfac
biologist
limit
bioinformat
experi
background
emerg
reemerg
infecti
diseas
seriou
advers
impact
societi
respect
live
lost
annual
econom
loss
wit
current
outbreak
caus
novel
coronaviru
march
confirm
case
around
globe
death
factor
climat
chang
urban
zoonot
spillov
intern
travel
lack
breakdown
public
health
care
system
natur
manmad
disast
pathogen
evolut
name
contribut
infecti
diseas
emerg
sustain
uniqu
challeng
associ
emerg
infecti
diseas
rapidli
identifi
etiolog
agent
develop
repurpos
exist
medic
countermeasur
mcm
includ
diagnost
assay
curtail
spread
outbreak
respect
reemerg
infecti
diseas
challeng
determin
whether
exist
mcm
effect
latter
case
develop
modifi
mcm
time
manner
case
failur
exist
mcm
account
genet
drift
shift
result
alter
genotyp
phenotyp
profil
newli
emerg
pathogen
ebolaviru
one
reemerg
infecti
diseas
agent
exhibit
high
degre
genet
chang
everi
new
outbreak
use
next
gener
sequenc
whole
genom
sequenc
wg
continu
releas
share
complet
genom
march
entir
research
commun
global
initi
share
influenza
data
gisaid
releas
wg
allow
us
test
biolaboro
pipelin
describ
studi
evalu
current
use
diagnost
assay
rapidli
design
new
assay
previou
studi
describ
bioinformat
tool
call
pset
pcr
signatur
eros
tool
use
show
silico
confirm
wet
lab
work
effect
exist
ebolaviru
diagnost
assay
larg
number
sequenc
avail
time
phrase
signatur
eros
use
signifi
potenti
falseposit
falseneg
result
pcr
assay
due
mutat
primer
probe
amplicon
target
sequenc
pcr
signatur
signatur
eros
could
also
mean
failur
medic
countermeasur
exampl
chang
genom
sequenc
result
amino
acid
chang
could
potenti
alter
efficaci
sequencebas
therapeut
studi
describ
expand
bioinformat
pipelin
call
biolaboro
integr
sever
tool
pset
endtoend
analysi
outbreak
pathogen
genom
sequenc
evalu
exist
pcr
assay
efficaci
new
sequenc
identifi
uniqu
signatur
region
bioveloc
design
pcr
assay
biolaboro
architectur
biolaboro
compris
three
algorithm
bioveloc
pset
built
pipelin
userfriendli
applic
user
option
launch
one
four
differ
job
type
signatur
discoveri
score
assay
target
valid
assay
new
assay
discoveri
three
algorithm
run
individu
togeth
complet
endtoend
pipelin
figur
bomv
use
case
first
phase
pipelin
bioveloc
use
analyz
set
genom
sequenc
uniqu
region
conserv
signatur
target
sequenc
select
achiev
split
chosen
repres
whole
genom
sequenc
slide
base
pair
bp
kmer
kmer
scan
target
sequenc
determin
conserv
conserv
kmer
elong
base
overlap
form
contig
contig
split
kmer
bp
scan
nontarget
sequenc
determin
specif
pass
sequenc
elong
base
overlap
signatur
contig
pass
next
step
pipelin
use
evalu
signatur
contig
identifi
suitabl
primer
probe
assay
develop
run
parallel
signatur
output
rank
penalti
score
ascend
order
top
five
best
primer
set
pass
along
final
step
pipelin
pset
step
primer
set
run
bioinformat
pipelin
align
sequenc
larg
public
sequenc
databas
ncbi
use
blast
glsearch
determin
well
assay
correctli
align
target
sequenc
exclud
offtarget
hit
even
two
assay
pass
silico
criteria
perfect
match
rais
possibl
assay
may
fail
wet
lab
test
due
mismatch
current
avail
bomv
genom
sequenc
henc
describ
design
new
assay
use
biolaboro
platform
discoveri
potenti
new
bomv
assay
use
biolaboro
endtoend
pipelin
use
biolaboro
ran
new
assay
discoveri
job
discov
new
bomv
signatur
determin
potenti
accur
detect
use
pset
first
phase
bioveloc
use
search
conserv
signatur
region
within
select
genom
select
organ
interest
search
bombali
ebolaviru
databas
select
three
avail
complet
genom
genom
use
algorithm
refer
sequenc
one
ncbi
select
refseq
databas
genbank
id
algorithm
refer
sequenc
first
split
kmer
bp
use
slide
window
bp
amount
kmer
evalu
bioveloc
conserv
sequenc
detect
algorithm
bioveloc
found
kmer
conserv
three
bomv
genom
conserv
kmer
evalu
determin
overlap
segment
combin
conserv
contig
contig
next
evalu
bioveloc
signatur
sequenc
detect
algorithm
contig
split
signatur
max
size
bp
longer
contig
split
kmer
step
size
conserv
kmer
sequenc
evalu
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
complet
genom
plasmid
ncbi
genbank
repositori
mer
sequenc
found
signatur
bomv
signatur
evalu
determin
overlap
read
combin
back
signatur
contig
metric
bioveloc
run
phase
one
shown
tabl
tabl
legend
five
new
assay
identifi
rank
lowest
penalti
score
identifi
column
autom
id
gener
pipelin
target
column
taxonomi
id
bomv
definit
column
contain
amplicon
sequenc
primer
bracket
orang
probe
parenthes
blue
penalti
point
column
contain
score
gener
take
account
primer
design
paramet
signatur
region
identifi
bioveloc
five
new
assay
select
map
bomv
genom
figur
shown
four
assay
cluster
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
third
phase
pset
use
test
five
newli
design
assay
identifi
silico
publicli
avail
sequenc
pset
use
analyz
primer
probe
new
assay
use
bioinformat
tool
identifi
potenti
falseposit
neg
match
ncbi
blast
nucleotid
sequenc
repositori
nt
gss
envnt
compris
million
sequenc
last
updat
septemb
blast
use
compar
assay
amplicon
sequenc
sequenc
repositori
identifi
match
match
use
creat
custom
librari
sequenc
glsearch
globalloc
sequenc
comparison
tool
fasta
suit
program
use
search
individu
primer
probe
result
output
process
filter
base
predefin
hit
accept
criteria
criteria
requir
assay
compon
hit
ident
compon
length
primer
pair
opposit
strand
total
amplicon
size
greater
bp
result
valid
compar
hit
target
ncbi
taxonomi
identifi
id
true
fals
match
report
pset
result
confirm
top
five
primer
set
true
posit
hit
three
bomv
genom
fals
posit
hit
organ
tabl
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
discoveri
potenti
assay
use
biolaboro
endtoend
pipelin
use
biolaboro
ran
new
assay
discoveri
job
discov
signatur
determin
potenti
true
posit
viral
detect
first
phase
bioveloc
use
search
conserv
signatur
region
within
select
genom
nineti
six
complet
whole
genom
sequenc
download
gisaid
upload
biolaboro
custom
databas
genom
use
refer
set
genbank
id
use
algorithm
refer
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
sequenc
algorithm
refer
sequenc
first
split
kmer
bp
use
slide
window
bp
amount
kmer
evalu
conserv
sequenc
detect
algorithm
bioveloc
found
kmer
conserv
genom
conserv
kmer
evalu
determin
overlap
segment
combin
conserv
contig
contig
next
evalu
bioveloc
signatur
sequenc
detect
algorithm
contig
split
tabl
second
phase
use
identifi
potenti
primer
pair
probe
gener
new
pcr
detect
assay
describ
bomv
primer
set
creat
signatur
assign
penalti
score
facilit
comparison
result
primer
set
sort
lowest
penalti
score
five
potenti
assay
chosen
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
manual
order
distribut
potenti
candid
across
genom
assay
format
sent
final
step
valid
use
pset
primer
set
sent
pset
shown
tabl
tabl
legend
five
new
assay
identifi
rank
lowest
penalti
score
identifi
column
autom
id
gener
pipelin
target
column
taxonomi
id
definit
column
contain
amplicon
sequenc
primer
bracket
orang
probe
parenthes
blue
penalti
point
column
contain
score
gener
take
account
primer
design
paramet
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
five
new
assay
map
genom
present
figur
figur
show
four
assay
one
locat
spike
gene
comparison
cdc
corman
group
assay
cluster
primarili
end
genom
envelop
e
nucleocapsid
phosphoprotein
n
gene
third
phase
pset
use
test
five
newli
design
assay
identifi
silico
publicli
avail
sequenc
describ
bomv
signatur
result
valid
compar
hit
target
ncbi
taxonomi
identifi
tabl
result
shown
alongsid
assay
cdc
corman
et
al
tabl
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
also
test
assay
use
pset
near
neighbor
sequenc
gener
outbreak
bat
pangolin
sequenc
expect
analys
show
rang
tp
pan
assay
fn
result
due
sequenc
diverg
tabl
tabl
pset
result
pcr
assay
bat
pangolin
sarscov
sequenc
sinc
discoveri
bomv
rna
detect
oral
rectal
swab
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
divers
ecolog
given
gap
human
econom
impact
ebolaviru
diseas
ongo
need
ebolaviru
biosurveil
character
bomv
avail
effici
viral
rna
detect
assay
critic
bio
surveil
reservoir
base
silico
analys
determin
current
ebov
assay
could
potenti
fail
detect
bomv
sequenc
thu
need
bomv
specif
assay
use
biolaboro
rapidli
design
evalu
new
specif
assay
advantag
bioveloc
end
user
obtain
result
quickli
high
confid
output
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mutat
alter
protein
sequenc
becam
appar
chang
monitor
impact
diagnost
vaccin
therapi
critic
outbreak
respons
earlier
studi
conduct
deciph
impact
thenavail
diagnost
determin
mani
realtim
revers
transcript
pcr
rrtpcr
assay
use
outbreak
use
silico
method
describ
two
ebov
rrtpcr
assay
evalu
bomv
target
sequenc
met
criteria
success
detect
neither
show
perfect
match
ongo
biosurveil
recommend
wet
lab
test
valid
rrtpcr
assay
describ
ensur
detect
bomv
also
test
biolaboro
pipelin
avail
viral
genom
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
contain
less
snp
except
one
none
variat
impact
diagnost
assay
signatur
howev
realtim
monitor
assay
wg
becom
avail
enabl
rapid
identif
signatur
eros
occur
gener
new
assay
need
newli
design
assay
describ
need
valid
wet
lab
test
appropri
clinic
matric
determin
perform
howev
demonstr
biolaboro
pipelin
use
effect
rapidli
valid
avail
assay
design
new
assay
use
genom
sequenc
newli
emerg
pathogen
period
rerun
biolaboro
emerg
reemerg
pathogen
sequenc
becom
avail
time
rel
divers
monitor
assay
updat
remain
current
regard
avail
data
track
assay
perform
measur
time
one
evalu
efficaci
mcm
routin
basi
analys
would
ensur
accur
mcm
avail
outbreak
respons
necessari
studi
demonstr
valu
realtim
genom
sequenc
mcm
evalu
provid
action
inform
public
health
emerg
combin
activ
biosurveil
zoonot
reservoir
gener
sequenc
data
understand
genet
divers
pathogen
biolaboro
broadli
applic
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
biolaboro
applic
rapidli
design
de
novo
assay
valid
exist
pcr
detect
assay
compos
three
tool
bioveloc
pset
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
system
attempt
determin
fit
result
primer
thu
allow
end
user
assess
signatur
yield
best
primer
signatur
may
similar
size
pset
configur
test
pcr
assay
silico
latest
version
public
test
current
deploy
assay
well
new
assay
design
use
biolaboro
capabl
biolaboro
applic
compos
fulli
function
gui
frontend
allow
user
submit
job
backend
bioinformat
pipelin
host
dedic
larg
ram
system
system
multius
capabl
discret
login
singl
job
queue
copyright
holder
preprint
peerreview
http
biolaboro
applic
allow
job
submiss
simplifi
user
interfac
design
scientist
minim
commandlin
experi
user
search
sequenc
interest
use
builtin
organ
select
tool
figur
allow
search
free
text
ncbi
access
number
ncbi
taxonomi
id
result
filter
use
smart
filter
includ
sequenc
within
calcul
median
genom
length
result
tool
use
automat
exclud
plasmid
sequenc
fragment
neg
impact
signatur
identif
altern
custom
sequenc
size
filter
also
use
user
want
target
specif
plasmid
chromosom
sequenc
select
ad
user
option
choos
specif
sequenc
serv
algorithm
refer
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
biolaboro
employ
queu
system
manag
job
submiss
due
high
comput
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
queue
includ
three
section
current
run
job
identifi
inform
current
subprocess
job
queue
shown
rearrang
need
finish
job
section
show
complet
job
timestamp
metadata
option
rerun
job
ident
paramet
databas
manag
set
page
contain
mani
option
maintain
system
data
pipelin
set
biolaboro
simpl
user
interfac
design
allow
user
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
gisaid
use
studi
signatur
creation
column
indic
sequenc
use
gener
signatur
valid
column
indic
sequenc
use
valid
signatur
pset
